Our study consistently supports the notion that TonEBP haploinsufficiency suppresses neuroinflammation in the diabetic brain and reduces steatosis in the liver, suggesting that HFD/STZ-induced TonEBP may be a detrimental factor eliciting chronic inflammation. Here, NFAT5 is linked to steatosis.